Join us when CFO Rob Gagnon explains how three recent transactions are helping Harvard Bioscience transform its business and open a new chapter of growth.
Made Possible By
“My priorities involve these transactions and helping to integrate the great company that we just acquired. We are now focused on organic growth as well and on driving top line growth. And I’ll be working with our CEO and management team to put plans in place to help grow this business before we go and do the next transaction.”